AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
Net Revenues of $56.334 Billion, an Increase of 3.7 Percent on a Reported Basis and 4.6 Percent on an Operational Basis Delivers Fourth-Quarter Net Revenues of $15.102 Billion, an Increase of 5.6 ...
Update on regulatory review of lecanemab for treatment of early Alzheimer's disease in the European Union
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee ...